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In this issue of Immunity, Liu et al. (2007) show that V(D)J recombinase binds chromatin marked by
H3K4 trimethylation. Because this mark associates with active promoters, the finding forges a new
link between transcription, epigenetics, and recombinase targeting during lymphocyte development.Adaptive immunity relies on the diver-
sification of antigen receptor genesdur-
ing B and T lymphocyte development.
Each precursor lymphocyte uses the
process of V(D)J recombination to as-
semble a unique variable region exon
for its immunoglobulin (Ig) or T cell re-
ceptor (TCR) genes from large arrays
of variable (V), diversity (D), and joining
(J) gene segments. All recombination
events are initiated by an enzymatic
complex (V(D)J recombinase), which is
composed of two proteins encoded by
recombination activating genes 1 and
2 (RAG1 and RAG2). The RAG1-RAG2
complex targets double-strand DNA
breaks toconserved recombination sig-
nal sequences (RSSs), which flank all Ig
and TCR gene segments. These breaks
are resolved by ubiquitous DNA repair
activities to irreversibly fuse selected
gene segments on the chromosome.
Because somatic rearrangement of
the genome is a risky business, diver-
sification comes at a cost. Aberrant
targeting of V(D)J recombination can
produce chromosomal translocations
that are initiating lesions in most leuke-
mias and lymphomas. As such, V(D)J
recombinasemust be stringently regu-
lated during lymphocyte development.
Indeed, recombinase targeting is con-
trolled by tissue specificity (TCR genes
rearrange in T but not B cell precur-
sors), stage specificity (Ig heavy- and
light-chain genes are assembled in
a specific order), and allele specificity
(only one allele of each gene is produc-
tively assembled per cell). Thus, tar-
geting and retargeting of recombinase
is critical for generating lineage-appro-
priate antigen receptors on precursor
lymphocytes, maintaining monospeci-ficity, and avoiding oncogenic trans-
locations.
The first clue to how recombinase is
targeted came from direct correlations
between transcription and recombina-
tion of specific gene segments. These
findings led to the hypothesis that
V(D)J recombination is regulated by
changes in chromatin, which either
augment or inhibit accessibility of DNA
to nuclear factors (e.g., RNA polymer-
ase and recombinase). Subsequent
studies showed that V(D)J recombi-
nation is regulated by transcriptional
promoters and enhancers distributed
throughout antigen receptor loci,
which coordinate changes in chroma-
tin accessibility at gene segment
clusters.
Like all cellular DNA, antigen recep-
tor loci associate with nucleosomes,
the basic building blocks of chromatin.
Nucleosomes themselves are com-
posed of histone octamers, usually
containing two of each canonical
histone—H2A, H2B, H3, and H4. Ac-
cessibility to DNA within a specific
chromatin domain is regulated by co-
valent modifications stamped on the
N-terminal tails of H3 and H4. The pat-
terns of epigenetic modification serve
as a ‘‘zip codes’’ for other proteins
that mediate localized opening or
compaction of chromatin. In general,
transcriptionally and recombination-
ally active chromatin is marked by H3
and H4 acetylation as well as meth-
ylation of H3 at lysine 4 (H3K4me)
(Morshead et al., 2003). In contrast,
chromatin that is refractory to RNA
polymerase and recombinase lacks
these marks but instead displays
H3K9me and H3K27me. Of particularImmunity 2note, genome-wide analyses have
shown that trimethylation of H3K4
(H3K4me3) is highly enriched around
active promoters (Heintzman et al.,
2007), one of the cis elements that
direct efficient V(D)J recombination.
Although extensive correlations were
established between histone modifi-
cations and recombination potential,
it remained amystery whether any epi-
genetic modification could serve as
a zip code for V(D)J recombinase.
Early studies exploring recombinase
function and its regulation by chroma-
tin were performed in vitro with trun-
cated, ‘‘core’’ versions of RAG1 and
RAG2 because of solubility problems
with the full-length proteins. Core
RAG complexes exhibit all requisite
RSS cleavage functions, which are in-
hibited by substrate association with
nucleosomes. However, evidence be-
gan to mount that the core RAG2 pro-
tein, which lacks much of its C termi-
nus, does not tell the complete story.
First, the noncore region of RAG2 is
evolutionarily conserved. Second, de-
letion of the RAG2 C terminus pro-
duces specific defects in recombina-
tion between distant V and DJ gene
segments, while sparing recombina-
tion between more closely spaced D
and J segments (Akamatsu et al.,
2003). Third, the C terminus of RAG2
interacts with all four basic histones
in vitro, albeit with a moderate affinity
(West et al., 2005). Fourth, Oettinger
and colleagues reported that the C ter-
minus of RAG2 contains a noncanoni-
cal plant homeodomain (PHD) (Elkin
et al., 2005), a protein motif recently
shown to bind various methylated
forms of H3K4 (Shi et al., 2006).7, October 2007 ª2007 Elsevier Inc. 539
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Immunity connects all of these dots
and reveals a new level of recombi-
nase control by demonstrating that
the RAG2-PHD binds to H3K4me3 on
cellular chromatin with functional con-
sequences (Liu et al., 2007). Initially,
they show that RAG2 binds specifi-
cally to H3 peptides bearing K4 meth-
ylation adducts but not other covalent
modifications. The authors use surface
plasmon resonance to demonstrate
that, although RAG2 can interact with
di- and trimethylatedH3K4, the highest
affinity interactions are with H3K4me3,
amarkenrichednear activepromoters.
Liu et al. (2007) then map H3K4me3
binding activity to the RAG2-PHD. Im-
portantly, a point mutation within this
domain (W453A) causes severe com-
bined immunodeficiency (SCID) in
humans and abrogates H3K4me3
binding. To rule out other mutational
effects, the authors show that RAG2-
W453A associates normally with
RAG1 and the mutant recombinase
complex has no defects in RSS bind-
ing or cleavage in vitro.
Of course, the major question is
whether RAG2-H3K4me3 interactions
are functionally relevant in the context
of antigen receptor gene assembly. To
address this issue, Liu et al. (2007)
take several complementary ap-
proaches. First, they show that RAG2-
PHD but not its W453A mutant version
pulls out recombinationally active Ig
gene segments from pro-B cell chro-
matin. The efficiency of association
with specific D and J segments in this
assay correlates well with relative
amounts of H3K4me3. Second, in con-
trast to wild-type RAG2, the W453A
mutant fails to rescue defects in DH/
JH recombination when introduced
into RAG2-deficient pro-B cells. A
similar defect was observed for the
W453A mutant in recombination as-
says with extrachromosomal sub-
strates, which also associate with
H3K4me3-marked chromatin. Be-
cause RAG2 and the W453A mutant
confer similar amounts of RSS cleav-
age in vitro, the logical conclusion
drawn by the authors is that binding of
H3K4me3 by RAG2-PHD enhances
the selection and recombination of
chromatinizedgenesegments indevel-
oping lymphocytes.540 Immunity 27, October 2007 ª2007 EFigure 1. Model for V(D)J Recombinase Targeting
Promoter- and enhancer-directed changes to chromatin generate RSS accessibility and anchor-
ing sites for the RAG complex. Chromatin opening of gene segment clusters initiates with en-
hancer (ENH) activation by nuclear factors (colored shapes), which leads to acetylation (star) of
surrounding nucleosomes (left). In this configuration, recombination signal sequences (RSSs,
green triangles) flanking distal gene segments remain inaccessible to the RAG1-RAG2 recombi-
nase complex. The activated enhancer stably interacts through space with promoters (PRO) situ-
ated near RSSs and the target gene segments (right). The promoter-enhancer holocomplex di-
rects revision of histone modifications throughout the cluster, changing them from repressive
(H3K9me, diamonds) to active (H3K9ac, stars; and H3K4me, hexagons) marks. In addition, the
holocomplex recruits nucleosome remodeling machinery that exposes flanking RSSs to recombi-
nase and triggers promoter-directed transcription. Transcriptional activation leads to high
amounts of the H3K4me3 mark at promoter-proximal positions. Recombinase initially binds to
the exposed RSS via RAG1. Liu et al. (2007) now demonstrate that the plant homeodomain
(PHD) portion of RAG2 binds with high affinity to the H3K4me3 mark, which likely stabilizes
recombinase interactions with RSSs and is required for rearrangement of chromatinized gene
segments.lThe new findings by Liu et al. (2007)
nicely triangulate what we knew about
the genetic and epigenetic mecha-
nisms controlling V(D)J recombination
with an inherent function of the RAG
complex. Together with prior studies,
the following model for recombinase
targeting has emerged (Figure 1). Dis-
tal enhancers associate with pro-
moters to form a new interaction sur-
face for the recruitment of nuclear
factors. Some of these factors revise
the pattern of histone modifications on
neighboring nucleosomes. Other fac-
tors recruited to thepromoter-enhancer
structure would directly remodel
neighboring nucleosomes to make as-
sociated DNA, including RSSs and
TATA elements, more accessible. To-
gether, these changes would lead to
transcription and elevated amounts
of the H3K4me3 mark, especially
near the promoter. RAG complexes
then bind to exposed RSSs and the
interaction is stabilized substantiallysevier Inc.by association between RAG2-PHD
and local H3K4me3 marks. This model
provides a satisfying explanation for
anumberof recentobservations, includ-
ing: (1) RAG complexes bind simulta-
neously to multiple RSSs throughout Ig
and TCR loci, which lie downstream of
transcriptionally active gene segments
(Curry et al., 2005), (2) promoters aug-
ment H3K4me3 and recombination of
gene segments in a highly localized
manner (Heintzman et al., 2007; Oes-
treich et al., 2006), and (3) premature
transcriptional termination reduces
H3K4me3 and inhibits recombination
of downstreamgene segments (Abarra-
tegui and Krangel, 2006).
As with any advance, the findings by
Liu et al. (2007) beg equally important
questions for future studies. Although
the current findings demonstrate as-
sociation of RAG complexes with
H3K4me3-marked chromatin, the full
specificity range of RAG-chromatin
interactions must be fleshed out.
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PreviewsBased on the authors’ data, one
would predict that RAG complexes
associate with bulk cellular chromatin
in a tissue-specific fashion (e.g., with
IgH but not TCR gene segments in
pro-B cells) and will not be brought
down with chromatin displaying re-
pressive marks (e.g., H3K9me3). Fu-
ture studies should also address
whether the transcriptional function of
promoters is required for recombinase
accessibility above and beyond pro-
moter-directed H3K4 methylation. As
the authors point out, the link between
H3K4me3 and RAG suggests at face
value that recombinase may be tar-
geted to almost any active gene in pre-
cursor lymphocytes. Clearly this is not
the case. An obvious source of addi-
tional specificity is the RSS, which is
bound by RAG1 and may synergize
with RAG2-H3K4me3 interactions to
generate a productive recombinase-
RSS complex. Alternatively, additional
chromatin modifications may contrib-
ute to a ‘‘histone code’’ for recombi-
nase targeting.
Lastly, Liu et al. (2007) show that
a PHD point mutation in the noncore
region of RAG2 (W453A) abrogates
DH/JH recombination in pro-B cells.
These data are in seeming contra-
diction with prior studies showingUbiquitin-Protea
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Phagocytosis is a complex proce
Silva et al. (2007) report that a pro
clearance of apoptotic cells in Dr
Thedenomination ‘‘phagocyte’’ comes
from the Greek phagein—to eat—
and kytos—cell—and was coined by
Metchnikoff (and Claus) when he dis-
covered phagocytosis while investi-that core RAG2, which lacks the entire
C terminus including the PHD, medi-
ates a normal degree of DH/JH
recombination but is defective for
VH/DHJH rearrangement. The au-
thors propose a highly testable model
to explain this apparent discrepancy.
They hypothesize that other parts of
the noncore RAG2 region impose an
inhibitory function on recombinase
that is counteracted by PHD bind-
ing to H3K4me3-marked chromatin. In
this model, the PHD mutation would
fail to relieve inhibition by the non-
core module, and recombination of
chromatinized substrates would be
blocked. In contrast, loss of the entire
RAG2 C terminus would generate an
active recombinase capable of rear-
ranging proximal (DH/JH) but per-
haps not distant (VH/DHJH) gene
segments. The latter, less efficient pro-
cess may benefit from the additional
punch provided by PHD-H3K4me3 in-
teractions. Notwithstanding, Liu et al.
(2007) have contributed an important
step in our quest to understand how
genetic elements coordinate the dy-
namic changes in transcription and
chromatin that drive stepwise as-
sembly of antigen receptor genes to
diversify our adaptive immune reper-
toire.some: Pallbearer
the Grave
Strasbourg Cedex, France
asbg.fr
ss that involvesmultiple cellular fu
tein ubiquitylation complex and th
osophila.
gating digestion in the starfish larva.
This mechanism is evolutionary very
ancient; it was possibly selected prior
to the invention of multicellularity by
early eukaryotic cells to ingest nutri-
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